Are Merck’s Declining Sales Of Januvia Related To Its Dangers?
Filed under:
The first quarter of 2013 was disappointing for stockholders in the pharmaceutical company Merck. Merck is the maker of Januvia, an oral medication used to treat Type-2 diabetes that has been an increasingly popular drug since its approval in 2006. However, recent research has clouded the outlook for the drug as the FDA commits to taking a closer look at the dangers that the drug may have for patients.
more »
Januvia Connection To Pancreatic Disease & Cancer
Januvia, similar to other …
